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A Continuum Variational Approach to Vesicle Membrane Modeling
Rolf Ryham1, Robert Eisenberg2, Chun Liu3, Fredric Cohen2.
1Fordham University, Bronx, NY, USA, 2Rush University Medical School,
Chicago, IL, USA, 3The Pennsylvania State University, University Park,
PA, USA.
Biological membranes remodel in lipid pore formation, fusion, endocytosis and
other processes. Traditionally, continuum membrane mechanics has been used
to describe the physics of these remodelings. Membrane mechanics is a conser-
vative, equilibrium theory and so cannot, a priori, describe the time course, flows
and dissipations of a real system. Over the past few decades, physical scientists
andmathematicians have developedglobalmulti-physics field equations that de-
scribe the time course of processes for condensedmatter in a thermodynamically
consistent way. We use these equations to describe the membrane during lipid
bilayer membrane remodelings. We analyze the vesicle membrane and its lipid
layers as a bulk continuum variable in a Hamiltonian. The Hamiltonian includes
the surface tension and curvature effects of the classicalHelfrichmodel. The rep-
resentations are, however, more flexible and can readily account for multicom-
ponent systems, inhomogeneities, and changes in topology. Coupling the
Hamiltonian to the motion of the aqueous medium with Rayleigh dissipation
leads to a complicated, self-consistent system of partial differential equations
that is solved numerically. Numerical schemes, designed specifically for this
field theory, provide the position, velocity and forces of the fluid–vesicle system
at each point in space and time. Classical models assume a specific shape for the
vesicle (e.g., a sphere). The assumed shapewill occur in the real world, however,
only if it is a self-consistent solution of the equations. Our calculations yield
values of all key variables and energies over time-the shape is an output. Movies
that precisely illustrate the time evolution of the membrane configuration are
generated. Changes over time are appreciated visually without reference to the
equations–or even to the physics–of the remodeling processes.
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Effects of JTV519 (K201) on Naþ- and Ca2þ Overload-Induced Arrhyth-
mogenic Ca2þ Release in Mouse Cardiac Myocytes
Frank R. Heinzel1, Michael Sacherer1, Simon Sedej1, Philipp Gronau1,
Marc Vos2, Jens Kockskaemper3, Burkert M. Pieske1.
1Medical University of Graz, Graz, Austria, 2Dept. of Medical Physiology,
UMC, Utrecht, Netherlands, 3Dept. of Pharmacology and Clinical Pharmacy,
Philipps University Marburg, Marburg, Germany.
Diastolic Ca2þ leak from the sarcoplasmic reticulum (SR) via the ryanodine re-
ceptor (RyR2) contributes to arrhythmias. Protein kinase A (PKA) and Ca2þ/
Calmodulin- dependent protein kinase II (CaMKII) have been involved in SR
Ca2þ leak by altering RyR2 gating. Under these conditions, JTV519 (K201),
a benzothiazepine derivate, has been shown to stabilize the modified RyR2
and reduce diastolic SR Ca2þ leak. We tested, whether JTV519 reduces SR
Ca2þ leak induced by Naþ- and Ca2þ overload (induced by 100 mM ouabain),
i.e. independent of CaMKII signaling. Methods: [Ca2þ]i was measured
(Fluo4-AM, confocal) in paced murine cardiomyocytes 5JTV519 (1 mM,
>1h preincubation). [Ca2þ]-transients, diastolic SR Ca2þ leak (Ca2þ spark
(SparkF, in s1*pL1) and Ca2þ wave frequency) and SR [Ca2þ] (caffein)
were measured5ouabain (OUAB) and KN93 (CaMKII-inhibitor, 1 mM). Phos-
phorylation of RyR2 (pSer2814, CaMKII site) was quantified by Western blot.
Results: With OUAB, total cellular [Ca2þ] increased from 3.350.3 to 4.350.3
(F/F0, mean5SE), SparkF increased from 31520 to 85530 (both p&lt;0.05).
Ouabain did not increase pSer2814, and KN93 had no effect on elevated
SparkF with ouabain (89524), indicating no contribution of CaMKII to in-
creased SR Ca2þ leak. JTV519 decreased SparkF (2554), and Ca2þ waves,
but also attenuated the increase in SR [Ca2þ] in OUAB (F/F0: 5.250.3 with
JTVþOuab vs. 7.750.6 OUAB, p&lt;0.05). However, matching cells for equal
SR [Ca2þ] revealed an SR [Ca2þ] - independent effect of JTV519 on SparkF. In
contrast, propagation speed of Ca2þ waves and the ratio between [Ca2þ] tran-
sient amplitude and SR [Ca2þ] were unchanged.
Conclusion: In conditions not related to CaMKII-mediated alterations of RyR2
gating, JTV519 reduces spontaneous SR Ca2þ release, but does not influence
propagated Ca2þ release or the fraction of SR Ca2þ released with each beat.
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AICAR Suppresses Intrinsic Ryanodine Receptor-Dependent Store-Oper-
ated Calcium Entry in CHO Cells
Jerome Parness, Balazs Lukacs, Daniela Requena.
Childrens’s Hosp Pitt-UPMC, Pittsburgh, PA, USA.
AICAR, an AMP-activated protein kinase (AMPK) agonist, increases the effi-
ciency of murine oxygen metabolism, dramatically increasing exercise endur-ance (Cell 134:405, 2008). AICAR also prevents heat-induced death in
malignant hyperthermia(MH)-susceptible transgenic mice (RyR1-Y522S/WT)
without changes in AMPK phosphorylation, and suppresses intracellular Ca2þ
levels by an unknown mechanism (Lanner JT et al, 2010 Biophysical Society
Meeting Abstracts). Store Operated Ca2þ Entry (SOCE) restores Ca2þ to de-
pleted sarcorendoplasmic reticulum fromextracellular stores. Since azumolene,
a drug which inhibits MH, suppresses the RyR1-dependent rise in intracellular
Ca2þ by inhibiting SOCE rather than Ca2þ release, we sought to determine
whether AICAR affects Ca2þ homeostasis similarly. We compared CHO cells
stably transfected with RyR1 (C1148) with wild type (CHO-wt). Single cell
Ca2þ imaging was performed in Fura-2 AM-loaded cells. Changes in intracellu-
lar Ca2þwere followed as changes in the ratio l340/380, and SOCEmeasured by
Mn2þ-quenching of Fura-2 fluorescence (l360). In C1148 cells, AICAR (1 mM,
overnight) suppresses Ca2þ-release by theRyR1 agonists, caffeine and4-Chloro-
m-Cresol (4-CMC). Western blot and immunofluorescence analysis do not
show any change in the expression of RyR1 or STIM1. The elevated SOCE in
C1148 cells is largely inhibited by AICAR (1 mM) and virtually completely by
the specific SOCE inhibitor BTP2 (1mM). SOCE stimulated by the SR Ca2þ-
pump inhibitor, CPA (10 mM), was inhibited by BTP2, but not by AICAR. The
ER Ca2þ store in C1148 cells is much lower than that of CHO-wt, irrespective
of AICAR treatment status. AICAR has no significant effect on [3H]ryanodine-
binding to skeletal muscle SR vesicles, nor does it have any effect on
sarcorendoplasmic reticulumCa2þ-ATPase activity.We conclude that AICAR,
like azumolene, partially inhibits the RyR1-dependent SOCE, but not Ca2þ-
ATPase-dependent SOCE.These data also suggest thatAICARmaybe therapeu-
tic in treating MH.
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Novel Mechanisms of CPVT1 in a RyR2-V2475F Knock-In Mouse Model
Randall Loaiza, Nancy A. Benkusky, Timothy A. Hacker,
Patricia A. Powers, Holli A. Loomans, Hector H. Valdivia.
UW-Madison, Madison, WI, USA.
Mutations in the cardiac ryanodine receptor (RyR2) have been implicated in
Catecholaminergic Polymorphic Ventricular Tachicardia 1 (CPVT1), an ar-
rhythmogenic syndrome triggered by emotional or physical stress in otherwise
healthy individuals. At the cellular level, the adrenergic surge during stress pre-
sumably induces diastolic SR Ca2þ release, generating a favorable substrate
for arrhythmias by the mechanism of delayed afterdepolarization (DAD). In-
creased sensitivity to luminal [Ca2þ], unzipping of domain-domain interac-
tions, and de-regulation by accessory proteins have been reported to
contribute to RyR2 dysfunction in CPVT1. We generated a knock-in mouse
model of CPVT1 (RyR2-V2475F) and characterized its mechanisms of arrhyth-
mia. Expression of RyR2-V2475F in HEK293 cells induces a unique pheno-
type, namely, increased activity at diastolic [Ca2þ] (pCa 7), which is not
seen in other CPVT1 mutations. Mice homozygous for the V2475F mutation
have not been detected in >500 mice, suggesting that the mutation causes cat-
astrophic RyR2 dysfunction and embryonic lethality. Heterozygous mice, on
the other hand, display increased propensity for premature ventricular com-
plexes, bidirectional ventricular tachycardia and other forms of tachyarryth-
mias when injected a cocktail of norepinephrine and caffeine that is mostly
innocuous in wild-type mice. Heterozygous Langendorff-perfused hearts sub-
jected to adrenergic stimulation and tachypacing are also arrhythmogenic, in-
dicating that the arrhythmias arise from mechanisms intrinsic to the heart
and not necessarily from systemic factors. Despite this severe phenotype, ven-
tricular cardiomyocytes isolated from RyR2-V2475F mice display only mild
differences in the amplitude and kinetics of intracellular Ca2þ transients
when compared to wild-type myocytes, regardless of stimulation frequency
and b-adrenergic stimulation. Thus, cellular Ca2þ mishandling in ventricular
myocytes of the RyR2-V2475F mice, although significant, does not appear suf-
ficient to support the severe phenotype observed in whole hearts and intact
mice. We are therefore investigating other mechanisms that may explain the
arrhythmogenicity of heterozygous mice.
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FRET-Based Mapping of Three Structural Domains within the Full-
Length Ryanodine Receptor Type 1
James D. Fessenden.
Boston Biomedical Research Institute, Watertown, MA, USA.
The type 1 ryanodine receptor (RyR1) mediates excitation contraction cou-
pling in skeletal muscle by releasing intracellular calcium in response to cell
depolarization. Understanding the structure and conformational dynamics of
RyR1 is challenging due to its size (homotetrameric subunit Mr~560 kDa)
and its association with numerous regulatory proteins. However, recent X-
ray crystallographic studies indicate that a fragment comprised of the first
200 amino acids of RyR1 folds into a compact b-trefoil domain. Based on
structural homology with the inositol trisphosphate receptor, the next 400
188a Monday, March 7, 2011amino acids of RyR1 are predicted to fold into a second b-trefoil and an alpha
helical domain. In this report, the relative orientation of these three domains
(termed here as b1, b2 and a1) within the full-length RyR1 protein has been
investigated using a novel FRET-based technique. This method monitors the
relative proximity of a GFP fluorescent donor fused into RyR1 and a fluores-
cent acceptor, Cy3NTA, targeted to poly-histidine (His) tags inserted into the
primary sequence of RyR1. In this study, GFP was fused to single positions
within b1, b2 and a1 and FRET was then measured to Cy3NTA targeted to
6 His tags singly introduced into these three domains. The results of these mea-
surements provide a detailed picture of the relative orientation of these three
sub-domains within full-length RyR1 expressed in a cellular context. Further
structural studies using this technique can now be undertaken to determine
how these domains move during channel gating. (Supported by NIH grant
R21ARO56406).
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3D Mapping of the SPRY2 Domain of RyR1 by Antibody Labeling and
Single-Particle cryo-EM
Alex Peralvarez-Marin1, HanShen Tae2, Philip G. Board2,
Marco G. Casarotto2, Angela F. Dulhunty2, Montserrat Samso3.
1Harvard University, Boston, MA, USA, 2John Curtin School of Medical
Research,Canberra,Australia, 3VCU School ofMedicine, Richmond, VA, USA.
The ryanodine receptor (RyR1) and the dihydropyridine receptor (DHPR) in-
teract functionally at the T tubule/sarcoplasmic reticulum interface of skeletal
muscle and are main participants of the excitation-contraction coupling pro-
cess. The SPRY2 domain of RyR1 has been shown to be relevant for the
RyR1/ DHPR interaction. Here, using a combination of immunolabeling and
single-particle cryo-EM we have mapped SPRY2 in the 3D structure of
RyR1. RyR1 was incubated with three different antibodies against the
SPRY2 domain and vitrified for cryo-EM imaging. The two main obstacles
for the image processing procedure; limited amount of data and signal dilution
introduced by the several possible binding locations of the antibody to the tet-
rameric RyR1, were overcome by modification of the 3D reconstruction
scheme. This enabled us to obtain a 3D reconstruction of RyR1 with the anti-
body bound, which in turn has allowed us to map the SPRY2 domain in
a T-tubule facing domain of RyR1.
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Localization of the Dantrolene Target Sequence in the Cardiac Ryanodine
Receptor by Combining cryo-EM and FRET Analysis
Zheng Liu1, Ruiwu Wang2, Xiaowei Zhong2, Andrea Koop2, Xing Meng1,
Xixi Tian2, Bradley Fruen3, S.R. Wayne Chen2, Terence Wagenknecht1.
1Wadsworth Center, New York State Department of Health, Albany, NY,
USA, 2Departments of Physiology and Pharmacology, and of Biochemistry
and Molecular Biology, University of Calgary, Calgary, AB, Canada,
3Department of Biochemistry, Molecular Biology, and Biophysics,
University of Minnesota, Minneapolis, MN, USA.
Mutations in ryanodine receptors (RyRs) cause calcium channel dysfunction in
two skeletal muscle diseases, malignant hyperthermia (MH) and central core
disease, and in polymorphic ventricular tachycardia in cardiac muscle. MH is
an inherited condition that causes muscle rigidity and uncontrollable fever in
reaction to administration of certain anesthetics. Dantrolene is a clinical drug
that suppresses spontaneous Ca2þ release and is used as a therapeutic agent
for individuals susceptible to MH. Recently, dantrolene has been shown to im-
prove cardiomyocyte function in failing hearts. Biochemical studies suggest
that the N-terminal region of RyR (amino acids 590-609 in RyR1
and 601-620 in RyR2) is the molecular target for dantrolene. We have
attempted to localize the dantrolene target sequence by 3D cryo-electron mi-
croscopy. However, inserting a GFP after Arg-626 in RyR2 abolished the
receptors’ binding to the GST-FKBP12.6 affinity column and prevented the
purification of RyR2R626-GFP for structural studies. As an alternative approach,
we designed several fluorescence resonance energy transfer (FRET) pairs based
on our previous cryo-EM structures to map the location of Arg-626. We
generated four pairs of dual insertions in RyR2 (RyR2S437-YFP/R626-CFP,
RyR2R626-CFP/Y846-YFP, RyR2S437-YFP/Y846-CFP, and RyR2R626-YFP/S2367-CFP);
three pairs between AF555-FKBP12.6 and RyR2-GFP (RyR2S437-GFP,
RyR2R626-GFP, and RyR2Y846-GFP); and three pairs between CFP-FKBP12.6
and RyR2-YFP (RyR2S437-YFP, RyR2R626-YFP, and RyR2Y846-YFP). We esti-
mated the 3D location of dantrolene binding sequence by measuring the
FRET efficiencies in each of these pairs, and by correlating FRET efficiencies
to the distance between donor and acceptor with known locations. Our results
reveal the dantrolene target sequence is likely to be located in the clamp region
close to the FKBP12.6 binding site.1032-Plat
Studies in the Binding of Calmodulin to Skeletal and Cardiac Ryanodine
Receptors
Kelvin Lau, Mandy M.Y. Chan, Filip Van Petegem.
UBC, Vancouver, BC, Canada.
Ryanodine receptors (RyR) are calcium release channels that are modulated by
cytosolic Ca2þ. They are a critical part in the process that leads to the contrac-
tion of skeletal and cardiac muscle. Calmodulin (CaM) is a ubiquitous calcium
sensor that can fine-tune the Ca2þ sensitivity of RyR by binding to regions ex-
posed to the cytoplasm. This modulation is isoform specific, depending on the
amount of free cytosolic Ca2þ. Here we used isothermal titation calorimetry to
determine the thermodynamic parameters of CaM binding to three distinct re-
gions in cardiac (RyR2) and skeletal muscle (RyR1) channels. Coupled with
alanine scanning, we have identified the critical anchor points in both regions
which mediate CaM binding to RyR. We show that CaM binding to RyR is iso-
form- and lobe- specific at high Ca2þ concentrations. At low Ca2þ concentra-
tions however, both isoforms behave similarily. The differences may underlie
the different functional effects of CaM on RyR1 and RyR2.
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The N-Terminal Disease Hot Spot of Ryanodine Receptors Forms a
Cytoplasmic Vestibule
Filip Van Petegem, Ching-Chieh Tung, Paolo A. Lobo, Lynn Kimlicka.
University of British Columbia, Vancouver, BC, Canada.
Ryanodine receptors (RyR) are ion channels that govern the release of Ca2þ
from the endoplasmic reticulum. They thus regulate the contraction of skeletal
and cardiac muscle. Mutations in RyR can lead to severe genetic conditions,
including (but not limited to) malignant hyperthermia (MH) and catecholamin-
ergic polymorphic ventricular tachycardia (CPVT). Despite the detailed inves-
tigation of the functional effects of the mutations, locating their position in the
full-length channel structure has traditionally proven to be difficult. Here we
present the 2.5 A˚ngstro¨m resolution crystal structure of a region spanning
most of the N-terminal disease hot spot (residues 1-559), containing over 50
disease mutations in RyR1 and RyR2. The hot spot consists of three domains
that interact through a predominantly hydrophilic interface. We have been
able to dock the position of this hot spot into various RyR1 cryo electron mi-
croscopy maps, allowing its unambiguous positioning in the cytoplasmic por-
tion of the channel, forming a 240-kDa ring around the fourfold symmetry
axis. The disease mutations can be grouped into three different categories, ei-
ther destabilizing the interfaces between the three N-terminal domains, affect-
ing the folding of individual domains, or affecting one of six interfaces with
other RyR parts. We propose a model whereby the opening of RyR coincides
with allosterically coupled motions within the N-terminal domains. This can
be affected by mutations that target various interfaces within and across sub-
units. We also propose a mechanism whereby RyRs are activated by redox
modification through the destabilization of observed domain-domain inter-
faces. The structure provides a framework to understand the many disease mu-
tations that have been studied using functional methods.
SYMPOSIUM 11: Interfaces Between Cells and
the Outside World: Bioengineering Meets
Biophysics
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Vertical Nanopillars For Highly-Localized Fluorescence Imaging in Live
Cells
Bianxiao Cui, Chong Xie, Lindsey Hanson, Carter Ziliang.
Stanford University, Stanford, CA, USA.
The rapidly evolving field of nanotechnology creates new frontiers for biolog-
ical sciences such as quantum dots for fluorescence imaging and nanotransistor-
based biosensors. Recently, vertical nanopillars protruding from a flat surface
has been shown to support cell survival and deliver large molecules into the at-
tached cells. Here we demonstrate (1) the use of vertically aligned SiO2 nano-
pillars to achieve below-the-diffraction limit observation volume in vitro and
inside live cells and (2) the use of vertical Pt nanopillars to enhance electrical
coupling between neuron cells and the recording electrodes. Transparent SiO2
nanopillars embedded in a nontransparent substrate restricts the propagation of
light and affords evanescence wave excitation along its vertical surface. This
effect creates high-localized illumination that can be used for single molecule
detection with high fluorescence background. We also fabricate vertically
aligned Pt nanopillars to enhance the electrical coupling between cultured
